These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38613246)

  • 1. GRADE guidance 37: rating imprecision in a body of evidence on test accuracy.
    Mustafa RA; El Mikati IK; Murad MH; Hultcrantz M; Steingart KR; Yang B; Leeflang MMG; Akl EA; Dahm P; Schünemann HJ
    J Clin Epidemiol; 2024 Jan; 165():111189. PubMed ID: 38613246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach.
    Zeng L; Brignardello-Petersen R; Hultcrantz M; Mustafa RA; Murad MH; Iorio A; Traversy G; Akl EA; Mayer M; Schünemann HJ; Guyatt GH
    J Clin Epidemiol; 2022 Oct; 150():216-224. PubMed ID: 35934265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting GRADE's levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?
    Schünemann HJ
    J Clin Epidemiol; 2016 Jul; 75():6-15. PubMed ID: 27063205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions.
    Schünemann HJ; Neumann I; Hultcrantz M; Brignardello-Petersen R; Zeng L; Murad MH; Izcovich A; Morgano GP; Baldeh T; Santesso N; Cuello CG; Mbuagbaw L; Guyatt G; Wiercioch W; Piggott T; De Beer H; Vinceti M; Mathioudakis AG; Mayer MG; Mustafa R; Filippini T; Iorio A; Nieuwlaat R; Marcucci M; Coello PA; Bonovas S; Piovani D; Tomlinson G; Akl EA;
    J Clin Epidemiol; 2022 Oct; 150():225-242. PubMed ID: 35934266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRADE guidelines 33: Addressing imprecision in a network meta-analysis.
    Brignardello-Petersen R; Guyatt GH; Mustafa RA; Chu DK; Hultcrantz M; Schünemann HJ; Tomlinson G
    J Clin Epidemiol; 2021 Nov; 139():49-56. PubMed ID: 34293434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings.
    Zeng L; Brignardello-Petersen R; Hultcrantz M; Siemieniuk RAC; Santesso N; Traversy G; Izcovich A; Sadeghirad B; Alexander PE; Devji T; Rochwerg B; Murad MH; Morgan R; Christensen R; Schünemann HJ; Guyatt GH
    J Clin Epidemiol; 2021 Sep; 137():163-175. PubMed ID: 33857619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRADE guidance 36: updates to GRADE's approach to addressing inconsistency.
    Guyatt G; Zhao Y; Mayer M; Briel M; Mustafa R; Izcovich A; Hultcrantz M; Iorio A; Alba AC; Foroutan F; Sun X; Schunemann H; DeBeer H; Akl EA; Christensen R; Schandelmaier S
    J Clin Epidemiol; 2023 Jun; 158():70-83. PubMed ID: 36898507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables.
    Schünemann HJ; Mustafa RA; Brozek J; Steingart KR; Leeflang M; Murad MH; Bossuyt P; Glasziou P; Jaeschke R; Lange S; Meerpohl J; Langendam M; Hultcrantz M; Vist GE; Akl EA; Helfand M; Santesso N; Hooft L; Scholten R; Rosen M; Rutjes A; Crowther M; Muti P; Raatz H; Ansari MT; Williams J; Kunz R; Harris J; Rodriguez IA; Kohli M; Guyatt GH;
    J Clin Epidemiol; 2020 Jun; 122():142-152. PubMed ID: 32058069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRADE guidelines 6. Rating the quality of evidence--imprecision.
    Guyatt GH; Oxman AD; Kunz R; Brozek J; Alonso-Coello P; Rind D; Devereaux PJ; Montori VM; Freyschuss B; Vist G; Jaeschke R; Williams JW; Murad MH; Sinclair D; Falck-Ytter Y; Meerpohl J; Whittington C; Thorlund K; Andrews J; Schünemann HJ
    J Clin Epidemiol; 2011 Dec; 64(12):1283-93. PubMed ID: 21839614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRADE Guidance: 31. Assessing the certainty across a body of evidence for comparative test accuracy.
    Yang B; Mustafa RA; Bossuyt PM; Brozek J; Hultcrantz M; Leeflang MMG; Schünemann HJ; Langendam MW
    J Clin Epidemiol; 2021 Aug; 136():146-156. PubMed ID: 33864930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks.
    Foroutan F; Guyatt G; Zuk V; Vandvik PO; Alba AC; Mustafa R; Vernooij R; Arevalo-Rodriguez I; Munn Z; Roshanov P; Riley R; Schandelmaier S; Kuijpers T; Siemieniuk R; Canelo-Aybar C; Schunemann H; Iorio A
    J Clin Epidemiol; 2020 May; 121():62-70. PubMed ID: 31982539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GRADE Working Group clarifies the construct of certainty of evidence.
    Hultcrantz M; Rind D; Akl EA; Treweek S; Mustafa RA; Iorio A; Alper BS; Meerpohl JJ; Murad MH; Ansari MT; Katikireddi SV; Östlund P; Tranæus S; Christensen R; Gartlehner G; Brozek J; Izcovich A; Schünemann H; Guyatt G
    J Clin Epidemiol; 2017 Jul; 87():4-13. PubMed ID: 28529184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GRADE guidelines: 6. Rating the quality of evidence: imprecision].
    Kulig M; Perleth M; Langer G; Meerpohl JJ; Gartlehner G; Kaminski-Hartenthaler A; Schünemann HJ
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):677-88. PubMed ID: 23200212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GRADE guidelines 20: Assessing the certainty of evidence in the importance of outcomes or values and preferences - inconsistency, imprecision, and other domains].
    Rissling O; Kaiser L; Schulz S; Langer G; Schwingshackl L
    Z Evid Fortbild Qual Gesundhwes; 2021 Aug; 164():79-89. PubMed ID: 34253480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains.
    Zhang Y; Coello PA; Guyatt GH; Yepes-Nuñez JJ; Akl EA; Hazlewood G; Pardo-Hernandez H; Etxeandia-Ikobaltzeta I; Qaseem A; Williams JW; Tugwell P; Flottorp S; Chang Y; Zhang Y; Mustafa RA; Rojas MX; Xie F; Schünemann HJ
    J Clin Epidemiol; 2019 Jul; 111():83-93. PubMed ID: 29800687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to interpret the certainty of evidence based on GRADE (Grading of Recommendations, Assessment, Development and Evaluation)].
    Schwingshackl L; Rüschemeyer G; Meerpohl JJ
    Urologe A; 2021 Apr; 60(4):444-454. PubMed ID: 33620513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using systematic reviews in guideline development: the GRADE approach.
    Zhang Y; Akl EA; Schünemann HJ
    Res Synth Methods; 2018 Jul; ():. PubMed ID: 30006970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.